Table 1.

Correlation Between CDC20 Expression and Clinicopathological Features of 97 DLBCL Patients

Characteristics	Cases, n	CDC20		χ2	P-value
		Lower, n	Higher, n
Gender
Male	49	29	20	0.112	0.738
Female	48	30	18
Age
≤60	63	41	22	1.365	0.243
>60	34	18	16
Stage
I–II	39	25	14	0.294	0.588
III–IV	58	34	24
B-symptoms
No	51	50	1	62.505	< 0.001
Yes	46	9	37
LDH
Normal	59	42	17	6.786	0.009
Elevated	38	17	21
IPI risk group
0–2	70	47	23	4.213	0.040
3–5	27	12	15
No. of extranodal sites
0–1	84	52	32	0.307	0.580
≥ 2	13	7	6

Abbreviations: CDC20, cell-division cycle 20; DLBCL, diffuse large B-cell lymphoma; IPI, international prognostic index; LDH, lactate dehydrogenase.